Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1

Fedde Groot1, Rogier W Sanders, Olivier ter Brake

  • 1Department of Human Retrovirology, Academic Medical Center, Meibergdreef 15, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Journal of Virology
|August 31, 2006
PubMed

Insights

Modifying antimicrobial peptides to enhance antifungal activity unexpectedly boosted human immunodeficiency virus type 1 (HIV-1) replication. This highlights potential risks of unintended consequences when altering innate immune peptides for therapeutic purposes.

Area of Science:

  • Immunology
  • Virology
  • Biochemistry

Background:

  • Antimicrobial peptides (AMPs) are crucial components of the innate immune system, protecting mucosal surfaces against pathogens.
  • Histatin 5, a salivary AMP, inhibits Candida albicans, a fungus causing oropharyngeal candidiasis in HIV-1 patients.
  • Previous research modified histatin 5's active domain, creating Dh-5 with enhanced fungicidal properties.

Purpose of the Study:

  • To investigate the anti-HIV-1 activity of the modified peptide Dh-5 and its derivatives.
  • To determine if modifications aimed at improving antifungal activity impact anti-HIV-1 efficacy.
  • To assess potential unintended consequences of AMP modification on viral replication.

Main Methods:

  • Testing Dh-5 and its derivatives for inhibition of HIV-1 replication in vitro.
  • Evaluating the effect of peptide variants on HIV-1 envelope-mediated cell entry.
  • Analyzing the mechanism by which peptides interact with viral and cellular membranes.

Main Results:

  • Dh-5 demonstrated some inhibition of HIV-1 replication, but none of its derivatives showed improved anti-HIV-1 activity.
  • One derivative, Dhvar2, significantly increased HIV-1 replication.
  • Dhvar2's mechanism likely involves facilitating viral and cellular membrane fusion, enhancing viral entry.

Conclusions:

  • Modification of AMPs can lead to unpredictable and detrimental side effects on other pathogens.
  • Improving antifungal activity of histatin 5 did not translate to enhanced anti-HIV-1 effects and could be counterproductive.
  • Careful consideration of off-target effects is necessary when developing modified AMPs for therapeutic use.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...